See more : MYND Life Sciences Inc. (MYNDF) Income Statement Analysis – Financial Results
Complete financial analysis of A SPAC I Acquisition Corp. (ASCA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of A SPAC I Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- PT Bundamedik Tbk (BMHS.JK) Income Statement Analysis – Financial Results
- MiMedx Group, Inc. (MDXG) Income Statement Analysis – Financial Results
- Bank Hapoalim B.M. (BKHYY) Income Statement Analysis – Financial Results
- EV Biologics, Inc. (YECO) Income Statement Analysis – Financial Results
- FIG (7708.TWO) Income Statement Analysis – Financial Results
A SPAC I Acquisition Corp. (ASCA)
Industry: Shell Companies
Sector: Financial Services
About A SPAC I Acquisition Corp.
A SPAC I Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecom industries in the United States and Asia. The company was incorporated in 2021 and is based in Singapore.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.52M | 504.91K | 3.38 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 2.52M | 504.91K | 3.38 |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.52M | 504.91K | 3.38 |
| Cost & Expenses | 2.52M | 504.91K | 3.38 |
| Interest Income | 1.83M | 1.01M | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K |
| EBITDA | -2.52M | -504.91K | -2.25K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.52M | -504.91K | -3.38 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.83M | 1.01M | 0.00 |
| Income Before Tax | -690.85K | 500.65K | -3.38 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -1.01K | -2.25K |
| Net Income | -690.85K | 500.65K | -3.38 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | -0.13 | 0.06 | 0.00 |
| EPS Diluted | -0.13 | 0.06 | 0.00 |
| Weighted Avg Shares Out | 5.43M | 7.75M | 1.50K |
| Weighted Avg Shares Out (Dil) | 5.43M | 7.75M | 1.50K |
NewGenIvf and A SPAC I Announce Closing of Business Combination
NewGenIvf and A SPAC I Announce Shareholder Approval of Business Combination
Source: https://incomestatements.info
Category: Stock Reports